Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Endocrinology
•
Pituitary Disorders
Should we be considering transsphenoidal surgical resection as first-line therapy for prolactinomas?
Wu, PMID 38253861
Answer from: at Community Practice
A dopamine agonist is the first line of treatment for prolactinomas because most patients respond well to this treatment and tolerate it.
Sign in or Register to read more
25433
Related Questions
What is the likelihood of recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients who develop immunotherapy induced adrenal insufficiency?
When and how do you taper off cabergoline therapy for treatment of microprolactinoma?
Would you consider treating empirically for AVP deficiency in a patient who had pituitary surgery 6 months earlier and complaints of polyuria/polydipsia with dilute urine (without performing water deprivation studies)?
Does norethindrone suppress FSH, LH completely?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
When do you recommend using L-arginine stimulated copeptin testing to evaluate for central diabetes insipidus (AVP-deficiency)?
When do you check macroprolactin in the evaluation of hyperprolactinemia?
Should we be aiming for normalization of both late-night salivary cortisol and 24hr urinary free cortisol levels when monitoring response to Cushing's disease treatment?
What is your approach to differentiating diabetes insipidus from primary polydipsia in the outpatient setting?
For patients with central hypothyroidism and a clear etiology (such as recent head irradiation), do you recommend brain imaging prior to starting thyroid hormone replacement therapy?